Medicare beneficiaries may pay less for 15 additional prescription drugs as early as 2027 as part of the next round of federal regulators' price negotiations with pharmaceutical manufacturers.

Big Pharma is again raising the prices for key medications that could save the lives of millions in Georgia and there are still more hikes to come.

The study in Nature Medicine reveals that alongside weight loss benefits, GLP-1 medications like Ozempic and Mounjaro may ...

GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and ...

News research shows GLP-1 medications may help treat a wide range of conditions, from addiction and dementia to heart disease ...

"These findings reinforce the use of dapagliflozin, 10 mg, or other SGLT2 inhibitors when the therapeutic goal is to reduce ...

Next up, Tremfya made a triumphant return to the 2024 roundup after falling off the rankings in 2023. The med's return came ...

The study revealed that weight-loss drugs significantly benefit neurological and behavioral health, including decreased risks ...

The Biden Administration enacted a slew of prescription drug cost reductions for seniors and citizens on Medicaid. The ...

A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...

A large study published in Nature Medicine reviewed the effects of GLP-1 drugs like Ozempic and Mounjaro on 175 different ...

Behavioral and Cognitive Improvement: By acting on brain regions related to appetite and addiction, these drugs not only ...